The group works on the design, synthesis, characterization and evaluation of lipid- and/or polymer-based nanostructured biomaterials. One specific interest lies in developing nanomaterials for healthcare and other medical applications, for example, drug delivery to improve or enable treatments of human diseases. In addition, we also seek to understand the fundamental sciences underlying the arenas of nanomedicine.
The Madhukar Group's research has revolved around electronic response (electrical and optical) of synthesized materials and structures in reduced (two, one, and zero) dimensions and their potential use in electronic and optoelectronic devices for information sensing, processing, imaging and computing technologies. The emphasis for some time has been on three dimensionally confined (i.e. zero dimensional) nanostructures called quantum dots and the scope in recent years has expanded to include biochemical materials (peptides, proteins) and hybrid semiconductor-biomolecular nanostructures for biomedical applications, particularly neural prostheses.